The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 25, 2006
Filed:
Jul. 01, 2002
Ulrike Bauer, Sandhausen, DE;
Zach Cheruvallath, San Diego, CA (US);
Ulrich Deuschle, Bammental, DE;
Elena Dneprovskaia, San Diego, CA (US);
Tim Gahman, Encinitas, CA (US);
Kristina Giegrich, Lampertheim, DE;
Ronnie Hanecak, San Clemente, CA (US);
Normand Hébert, Cardiff, CA (US);
John Kiely, San Diego, CA (US);
Ingo Kober, Gaiberg, DE;
Manfred Kögl, Eppelheim, DE;
Harald Kranz, Leimen, DE;
Claus Kremoser, Heidelberg, DE;
Matthew Lee, Solana Beach, CA (US);
Kerstin Otte, Heidelberg, DE;
Carlton Sage, Cardiff, CA (US);
Manish Sud, San Diego, CA (US);
Ulrike Bauer, Sandhausen, DE;
Zach Cheruvallath, San Diego, CA (US);
Ulrich Deuschle, Bammental, DE;
Elena Dneprovskaia, San Diego, CA (US);
Tim Gahman, Encinitas, CA (US);
Kristina Giegrich, Lampertheim, DE;
Ronnie Hanecak, San Clemente, CA (US);
Normand Hébert, Cardiff, CA (US);
John Kiely, San Diego, CA (US);
Ingo Kober, Gaiberg, DE;
Manfred Kögl, Eppelheim, DE;
Harald Kranz, Leimen, DE;
Claus Kremoser, Heidelberg, DE;
Matthew Lee, Solana Beach, CA (US);
Kerstin Otte, Heidelberg, DE;
Carlton Sage, Cardiff, CA (US);
Manish Sud, San Diego, CA (US);
Phenex Pharmaceuticals AG, , DE;
Abstract
The present invention relates to compounds according to the general formula (I) which bind to the nuclear receptor, NR1H4, and act as agonists and antagonists of the NR1H4 receptor. The invention further relates to the treatment of diseases and/or conditions through binding of the nuclear receptor by the compounds.